FDA approves IlluminOss resin for aging, osteoporosis-related fractures

A BALLOON CATHETER and optical fiber are inserted through a tiny incision, in the IlluminOss Photodynamic Bone Stabilization System. A light-sensitive glue is infused into the balloon, in images 2 and 3, then light is used to activate and rapidly harden the compound. / COURTESY ILLUMINOSS MEDICAL
A BALLOON CATHETER and optical fiber are inserted through a tiny incision, in the IlluminOss Photodynamic Bone Stabilization System. A light-sensitive glue is infused into the balloon, in images 2 and 3, then light is used to activate and rapidly harden the compound. / COURTESY ILLUMINOSS MEDICAL
EAST PROVIDENCE —IlluminOss Medical has received U.S. Food and Drug Administration clearance to use its IlluminOss Bone Stabilization System using light-sensitive resin to treat osteoporosis and age-related fractures, the company announced today. The East Providence-based, privately held, commercial-stage medical device company won FDA de novo clearance fractures of the humerus, radius and ulna from metastatic bone…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -